Evaluate the Efficacy and Safety of JMKX003002 in End-Stage Renal Disease Patients on Hemodialysis with Hyperphosphatemia

Clinical trial NCT06664125 · RECRUITING

Trial details

NCT number: NCT06664125
Sponsor: Jemincare
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hyperphosphatemia

Start date: 2024-12-30
Primary completion: 2025-06-30
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.